Grave's disease research hub

A Proof-of-Concept, Open-label Study to Assess the Safety and Efficacy of Batoclimab in Participants with Graves’ Disease (GD)

This study is testing a new medicine, Batoclimab, for Graves' disease. Researchers want to see if it's safe and helps control thyroid hormone levels, aiming for them to be normal or lower, without needing more of current thyroid medication.